Two key developments in US oncology signal faster progress: a new standard therapy for aggressive colorectal cancer and …
Two key developments in US oncology signal faster progress: a new standard therapy for aggressive colorectal cancer and …
A landmark study from MHRA and University of Liverpool reveals the UK’s leadership in drug development and outlines …
Fresh guidelines and a reshaped regulatory framework pave the way for smoother clinical research, even as COVID-19 maintains …
Prime Minister Starmer unveils ambitious reforms to speed up trial timelines and centralize NHS data, aiming to restore …
An investigational RNA-based therapy shows significant reduction in disease-causing protein levels—potentially a meaningful step forward in treating Huntington’s …
Megafunding rounds and regulatory momentum reshaped the biotech investment landscape, signaling growing confidence in transformative clinical innovation.
Topical laquinimod reaches posterior eye tissues with dose-related distribution and good tolerability in patients preparing for vitrectomy
The biotech sector saw compelling developments from funding milestones to shifts in trial regulations and rising promise in …
Early-stage data reveal tumour targeting and tolerability with radiolabelled GRPR antagonist therapy in metastatic prostate cancer
New AI-powered system promises to reduce inefficiencies in trial recruitment by automating eligibility prediction
